Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Neupro Now Available in Canada to Treat Parkinson's Disease
Sept. 3, 2013
The availability of neupro in Canada follows Health Canada's approval in March, making it the first new treatment for Parkinson's disease approved in Canada in five years. Neupro is the first and only non-ergolinic dopamine agonist available in a patch, and provides 24-hour delivery of rotigotine through the skin into the bloodstream.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing